OUR WHY
Brian Elfus is a basketball industry veteran who has negotiated more than $750 million in contracts throughout his 22 year career. His impressive client roster includes NBA and G League Head Coaches, NBA Executives, and NBA Assistant Coaches. Plus, NCAA Division I Head Coaches and Assistant Coaches.
When he’s not hard at work, Brian is focused on his family. Married for 30 years, Lori has been the center of his world since they first met at American University in Washington, DC. Their life has been full of joy and laughter but took turn in April 2019 when Lori suffered a brain aneurysm. After having a successful surgery to address the clotted blood vessel, Lori was diagnosed with Fibromuscular Dysplasia. The disease, commonly known as FMD, is characterized by abnormal cell growth within the material wall. There is no cure for FMD so for women like Lori, you live to manage the symptoms.
Roberta, Brian’s mother, has been a pillar of strength for the entire Elfus Family, as they navigated uncharted waters. Roberta was diagnosed Scleroderma and spent 25 years battling an auto-immune disease that hardens and tightens the skin and connective tissue. Sadly, Roberta passed away on September 25, 2022, shortly after attending the inaugural ESM Foundation Charity Golf Tournament.
As you can imagine, Brian is more determined than ever to make his annual fundraiser a success.
Who We Support
The Fibromuscular Dysplasia Society of America (FMDSA) is a not-for-profit patient advocacy organization working towards better diagnosis and treatment of Fibromuscular Dysplasia (FMD). FMDSA builds awareness of FMD, funds research activities, provides support and educating patients and the health care community. FMDSA works to inspire and facilitate collaboration between national and international organizations devoted to FMD and FMD-related research, education, and patient care.
The Scleroderma Research Foundation (SRF) is the United States’ leading 501(c)3 nonprofit investor in scleroderma research and is laser-focused on finding a cure for scleroderma, a rare and deadly disease. Led by the most distinguished scientific minds, the SRF research program seeks to understand scleroderma by facilitating collaboration among the world’s top scientists and medical institutions.
SRF strives to increase awareness and knowledge of scleroderma among those living with scleroderma, the medical community, and the general public. As an innovator in scleroderma research, the SRF is uniquely qualified to provide those living with scleroderma, the medical community, and the general public with the most up-to-date and relevant news and information about complications, treatments, and related research.
